መነሻ › ዲፊዩዝ ኢንትሪንሲክ ፖንታይን ግሊዎማ › Pennsylvania
በPennsylvania ለዲፊዩዝ ኢንትሪንሲክ ፖንታይን ግሊዎማ የሚደረጉ ክሊኒካዊ ጥናቶች
ለዲፊዩዝ ኢንትሪንሲክ ፖንታይን ግሊዎማ የሚደረጉ 12 ጥናቶች በPennsylvania ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በPennsylvania ውስጥ ያሉ ከተሞች
Official study text (English)
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
- Children's Hospital of Philidelphia, Philidelphia
ተሳታዮችን በመፈለግ ላይደረጃ 2
12 Months – 39 Years · ሁሉም ጾታዎች · የተሻሻለው በ21 ሴፕቴ 2026 · NCT06838676CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- Children's Hospital of Philadelphia, Philadelphia
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
12 Months – 21 Years · ሁሉም ጾታዎች · የተሻሻለው በ11 ሴፕቴ 2026 · NCT04870944Targeted Pediatric High-Grade Glioma Therapy
- Children's Hospital of Philadelphia, Philadelphia
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
12 Months – 39 Years · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT05839379Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
- Penn State Milton S. Hershey Medical Center and Children's Hospital, Hershey
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እስከ እድሜ 26 · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT06465199Study of Olutasidenib and Temozolomide in HGG
- Children's Hospital of Philadelphia, Philadelphia
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ12 እስከ 39 · ሁሉም ጾታዎች · የተሻሻለው በ1 ሴፕቴ 2026 · NCT06161974PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
- Children's Hospital of Philadelphia, Philadelphia
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ3 እስከ 39 · ሁሉም ጾታዎች · የተሻሻለው በ24 ኦገስ 2026 · NCT05096481Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
- Children's Hospital of Philadelphia, Philadelphia
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ1 እስከ 26 · ሁሉም ጾታዎች · የተሻሻለው በ4 ኦገስ 2026 · NCT07680439Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors
- Children's Hospital of Philadelphia, Philadelphia
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ4 እስከ 39 · ሁሉም ጾታዎች · የተሻሻለው በ20 ጁላይ 2026 · NCT05278208Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
- Children's Hospital of Philadelphia, Philadelphia
ተሳታዮችን በመፈለግ ላይየመጀመሪያ ደረጃ 1ጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ1 እስከ 21 · ሁሉም ጾታዎች · የተሻሻለው በ29 ጁን 2026 · NCT06333899Combination Therapy for the Treatment of Diffuse Midline Gliomas
- Children's Hospital of Philadelphia, Philadelphia
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ2 እስከ 39 · ሁሉም ጾታዎች · የተሻሻለው በ26 ጁን 2026 · NCT05009992Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
- Children's Hospital of Philadelphia, Philadelphia
ተሳታዮችን በመፈለግ ላይደረጃ 2
12 Months – 39 Years · ሁሉም ጾታዎች · የተሻሻለው በ29 ሜይ 2026 · NCT05843253A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
- Children's Hospital of Philadelphia, Philadelphia
ተሳታዮችን በመፈለግ ላይየመጀመሪያ ደረጃ 1
እስከ እድሜ 21 · ሁሉም ጾታዎች · የተሻሻለው በ18 ማርች 2026 · NCT04655404ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።